Seagen (Canada)

Seagen (Canada)

Seagen Inc. is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Seagen (Canada), Canada, covering academic research published from 2001 to 2025. Read More.


Open Access Percentage

69%


Total
Publications

52


Total Open
Publications

36


Total
Citations

5.2K


Open Access
Percentage

69%


Total
Publications

52


Total Open
Publications

36


Total
Citations

5.2K

Wikipedia

Website

download

Breakdown

27% 25% 17% 31%

Publisher Open

27%

Both

25%

Other Platform Open

17%

Closed

31%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

012345678Total Publications
2001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Open

Closed

Publisher Open

19%OA Journal

OA Journal 19%

5

Hybrid 33%

9

No Guarantees 48%

13

Other Platform Open

Domain 73%

16

Institution 36%

8

Preprint 14%

3

Other Internet 9%

2

Public 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
16
Research Square
Preprint
3
DOI
Other Internet
2
doaj.org OAI-PMH Repository
Institution
2
University of Southern Denmark
Institution
1
University of Debrecen
Institution
1
University of Copenhagen
Institution
1
Universidad San Ignacio de Loyola
Institution
1
Royal Netherlands Academy of Arts and Sciences
Institution
1
Leiden University
Institution
1
1 / 2

Data updated 12 August 2026

Share

Share

Share